Kharfan-Dabaja, M A <br/><br/>
Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitors.  [electronic resource] 

 -  Leukemia  Mar 2014 
 - 507-17 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2013.311  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Agammaglobulinaemia Tyrosine Kinase<br/>Cell Transplantation<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Immune Tolerance--drug effects<br/>Immunotherapy<br/>Lenalidomide<br/>Leukemia, Lymphocytic, Chronic, B-Cell--therapy<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Thalidomide--analogs & derivatives